TRCLF(TRCLF)
TRCLF
No analyst ratings available
No analyst price targets available for TRCLF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $413.38B | $434.18B | $456.13B | $469.31B |
| Low | $410.58B | $429.10B | $451.89B | $464.94B |
| High | $416.19B | $439.27B | $460.38B | $473.68B |
| EBITDA Avg | $28.33B | $29.76B | $31.26B | $32.17B |
| Low | $28.14B | $29.41B | $30.97B | $31.87B |
| High | $28.52B | $30.11B | $31.55B | $32.46B |
| EBIT Avg | $21.87B | $22.97B | $24.13B | $24.82B |
| Low | $21.72B | $22.70B | $23.90B | $24.59B |
| High | $22.01B | $23.24B | $24.35B | $25.06B |
| Net Income Avg | $13.71B | $14.49B | $15.38B | $15.01B |
| Low | $13.54B | $14.32B | $15.20B | $14.83B |
| High | $13.87B | $14.67B | $15.57B | $15.20B |
| EPS Avg | $343.19 | $362.79 | $385.10 | $375.89 |
| Low | $339.04 | $358.40 | $380.44 | $371.34 |
| High | $347.34 | $367.18 | $389.76 | $380.44 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $104.23B | $105.12B | $105.84B |
| Low | $104.23B | $105.12B | $105.84B |
| High | $104.23B | $105.12B | $105.84B |
| EBITDA Avg | $7.14B | $7.20B | $7.25B |
| Low | $7.14B | $7.20B | $7.25B |
| High | $7.14B | $7.20B | $7.25B |
| EBIT Avg | $5.51B | $5.56B | $5.60B |
| Low | $5.51B | $5.56B | $5.60B |
| High | $5.51B | $5.56B | $5.60B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |